title: Recommendations in debate on psychiatric drugs are insufficiently justified.
authors.affiliation: London SW1Y 4QX, UK dtovey@cochrane.org.
authors.forename: David
authors.initials: D
authors.lastname: Tovey
authors.affiliation: University of Bristol, Bristol, UK.
authors.forename: Rachel
authors.initials: R
authors.lastname: Churchill
authors.affiliation: Institute of Mental Health, University of Nottingham, Nottingham, UK.
authors.forename: Clive E
authors.initials: CE
authors.lastname: Adams
authors.affiliation: Queen's University, Belfast, UK.
authors.forename: Geraldine
authors.initials: G
authors.lastname: Macdonald
mesh_terms: D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects*; D013405:Suicide / Q000706:statistics & numerical data*
chemical_list: D011619:Psychotropic Drugs